Clinical Trial Update: Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating safety and efficacy of Q-122 in breast cancer patients on tamoxifen or aromatase inhibitors.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Q-122

Snippet

Sponsor: Que Oncology | Conditions: Vasomotor Symptoms (VMS) | Phase 2 | Status: COMPLETED